查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1635780

马兽医治疗市场：全球产业分析、市场规模、占有率、成长、趋势和预测（2025-2032 年）

Equine Veterinary Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 142 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了对全球马兽医治疗市场的全面分析。该报告对市场推动因素、趋势、机会和课题等关键市场动态进行了全面的评估，并对市场结构提供了详细的见解。该报告提供了独家数据和统计数据，概述了全球马兽药市场的预期成长轨迹（2025-2032 年）。

主要的洞察

  • 马兽药市场规模（2025 年）：14 亿美元
  • 市场规模预测（价值基础，2032 年）：23 亿美元
  • 全球市场成长率（CAGR，2025-2032）：6.7%

马兽医治疗市场：分析范围

马兽医治疗对于预防、诊断和治疗影响马匹的健康状况至关重要。该市场包括针对马匹特定需求而量身订製的药品、疫苗和营养补充品。这些药物被兽医、马科诊所和马主广泛用于治疗感染、关节疾病、寄生虫感染和其他健康问题。市场成长的动力来自于人们对马匹健康认识的不断提高、对马术运动的投资不断增加以及兽医学的进步。市场也受益于扩大采用疫苗和营养补充剂等预防性护理解决方案来确保马匹的健康。

市场成长动力：

全球马兽医治疗市场受到几个关键因素的推动，包括马绞痛、蹄叶炎和马流感等马疾病的盛行率不断上升。越来越多的人参与马术运动和娱乐活动，促使人们对马匹健康的兴趣增加，兽医护理支出也增加。此外，生物技术的进步促进了标靶疗法的发展，提高了治疗效果并最大限度地减少了副作用。马主对预防性医疗保健重要性的认识不断提高也是推动疫苗和营养补充剂需求的关键因素。马科动物诊所网路的不断扩大和先进诊断工具的日益普及进一步推动了市场的成长。

市场限制：

儘管马兽医治疗市场成长前景看好，但它面临着治疗成本上升、兽医专家短缺和监管障碍等课题。马药和疫苗的费用对小型马主来说太昂贵，特别是在可支配收入有限的新兴国家。此外，有关兽药审批和使用的严格规定给製造商带来了合规负担，从而减缓了产品的推出。某些疗法相关的副作用风险以及马匹医疗治疗缺乏足够的保险覆盖进一步抑制了市场的成长。

市场机会：

在技术创新、城市化进程加快和马匹护理标准不断发展的推动下，马兽医治疗市场提供了巨大的成长机会。马匹穿戴式监测设备等数位健康技术的整合将增强疾病的早期发现并促进预防性护理。此外，新型生物製剂和基因疗法的开发为治疗以前无法治癒的疾病开闢了新的途径。马术旅游日益普及以及人们对伴侣动物健康的日益关注为市场参与者创造了更多机会。预计研发方面的策略性投资以及製药公司和马术组织之间的合作将推动市场扩张。

本报告解答的关键问题

  • 推动全球马兽医治疗市场成长的关键因素有哪些？
  • 哪些产品领域需求量最大？
  • 兽医学的进步如何影响马匹治疗市场的竞争格局？
  • 马兽医治疗市场的主要参与者是谁？他们采用了什么策略来维持市场竞争力？
  • 全球马兽医治疗市场有哪些新兴趋势与前景？

目录

第 1 章执行摘要

第二章 市场概览

  • 市场范围与定义
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
    • 课题
    • 主要趋势
  • 药品生命週期分析 马兽药市场：价值链
    • 原物料供应商名单
    • 製造商列表
    • 经销商名单
    • 用途列表
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 宏观经济因素
    • 全球产业展望
    • 全球 GDP 成长前景
    • 全球母公司市场概览
  • 预测因子：相关性和影响力
  • 监管与技术格局

第 3 章。
  • 主要亮点
    • 市场规模预测（基于数量）
    • 市场规模与年成长率
    • 绝对的获利机会
  • 市场规模分析与预测（价值基础（十亿美元））
    • 过往市场规模分析（2019-2023 年）
    • 当前市场规模预测（2025-2032）
  • 全球马兽药市场展望（依药物类别）
    • 简介/主要发现
    • 按药物类型划分的历史市场规模表现（价值（十亿美元）和数量，2019 年至 2023 年）
    • 按药物类型划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 抗发炎剂
      • 抗感染药物
      • 解毒剂
      • 其他
  • 依药物进行市场吸引力分析
  • 按给药途径划分的全球马兽药市场展望
    • 简介/主要发现
    • 按给药途径划分的历史市场规模表现（价值（十亿美元）和数量，2019 年至 2023 年）
    • 按给药途径划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 口服
      • 肠外
      • 本地
  • 依给药途径进行市场吸引力分析
  • 全球马兽药市场展望（按服务）
    • 简介/主要发现
    • 按服务划分的历史市场规模表现（价值（十亿美元）和数量，2019 年至 2023 年）
    • 目前按服务划分的市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 诊断测试和影像
      • 身体健康监测
      • 手术
      • 疫苗接种
      • 其他
  • 依服务进行市场吸引力分析
  • 按通路划分的全球马兽药市场展望
    • 简介/主要发现
    • 按分销管道划分的历史市场规模表现（价值（十亿美元）和数量，2019 年至 2023 年）
    • 按分销管道划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 兽医诊所
      • 兽医诊所
      • 药局和药局
      • 电子商务
      • 其他
  • 依分销管道进行市场吸引力分析

4. 全球马兽药市场按地区展望

  • 主要亮点
  • 按地区划分的历史市场规模分析（价值（十亿美元）和数量，2019 年至 2023 年）
  • 按地区划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区进行市场吸引力分析

第 5 章。

第 6 章。

第 7 章。

8. 南亚和大洋洲马兽医治疗市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 9 章。

第 10 章。

第 11 章 竞争格局

  • 市占率分析（2023年）
  • 市场结构
    • 竞争加剧图：依市场划分
    • 竞争资讯中心
    • 生产能力（表观值）
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Merck Animal Heath
    • Affymetrix
    • Elanco Animal Health
    • Zoetis (Pfizer Animal Health)
    • Equine Health UK

第 12 章附录

  • 分析法
  • 分析前提条件
  • 缩写和缩写
简介目录
Product Code: PMRREP33965

Persistence Market Research has recently released a comprehensive report on the worldwide market for equine veterinary therapeutics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global equine veterinary therapeutics market from 2025 to 2032.

Key Insights:

  • Equine Veterinary Therapeutics Market Size (2025E): USD 1.4 Billion
  • Projected Market Value (2032F): USD 2.3 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.7%

Equine Veterinary Therapeutics Market - Report Scope:

Equine veterinary therapeutics are critical for the prevention, diagnosis, and treatment of health conditions affecting horses. The market includes pharmaceuticals, vaccines, and nutritional supplements tailored to address equine-specific needs. These therapeutics are extensively used by veterinarians, equine clinics, and horse owners for the management of infections, joint disorders, parasitic infestations, and other health issues. Market growth is driven by rising awareness of equine health, increasing investments in equestrian sports, and advancements in veterinary medicine. The market also benefits from the growing adoption of preventive care solutions, such as vaccines and nutritional supplements, to ensure the well-being of horses.

Market Growth Drivers:

The global equine veterinary therapeutics market is propelled by several key factors, including the increasing prevalence of equine diseases such as colic, laminitis, and equine influenza. Rising participation in equestrian sports and recreational activities has elevated the focus on horse health, leading to higher spending on veterinary care. Moreover, advancements in biotechnology have resulted in the development of targeted therapies, enhancing treatment efficacy and minimizing side effects. Another critical driver is the growing awareness among horse owners about the importance of preventive healthcare, which has boosted the demand for vaccines and nutritional supplements. The expanding network of equine clinics and the rising availability of advanced diagnostic tools further support market growth.

Market Restraints:

Despite promising growth prospects, the equine veterinary therapeutics market faces challenges related to high treatment costs, limited availability of specialized veterinarians, and regulatory hurdles. The cost of equine pharmaceuticals and vaccines can be prohibitive for small-scale horse owners, particularly in emerging economies with limited disposable income. Additionally, stringent regulations governing the approval and use of veterinary drugs create compliance burdens for manufacturers and delay product launches. The risk of adverse effects associated with certain therapies and the lack of adequate insurance coverage for equine healthcare further restrain market growth.

Market Opportunities:

The equine veterinary therapeutics market presents significant growth opportunities driven by technological innovations, increasing urbanization, and evolving equine care standards. The integration of digital health technologies, such as wearable monitoring devices for horses, enhances early disease detection and promotes preventive care. Furthermore, the development of novel biologics and gene-based therapies opens new avenues for the treatment of previously untreatable conditions. The rising popularity of equestrian tourism and the growing focus on companion animal health create additional opportunities for market players. Strategic investments in research and development, coupled with collaborations between pharmaceutical companies and equestrian organizations, are expected to drive market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the equine veterinary therapeutics market globally?
  • Which product segments are experiencing the highest demand, and why?
  • How are advancements in veterinary medicine influencing the competitive landscape of the equine therapeutics market?
  • Who are the key players in the equine veterinary therapeutics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global equine veterinary therapeutics market?

Competitive Intelligence and Business Strategy:

Leading players in the global equine veterinary therapeutics market, including Zoetis Inc., Merck Animal Health, and Boehringer Ingelheim, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies are investing in R&D to develop advanced therapies, including long-acting injectable drugs, biologics, and targeted treatments for chronic conditions like arthritis and laminitis. Partnerships with equine healthcare providers, equestrian associations, and veterinary schools facilitate product adoption and market penetration.

Key Companies Profiled:

  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Virbac
  • Ceva Sante Animale
  • Vetoquinol S.A.

Equine Veterinary Therapeutics Industry Segmentation

By Drugs:

  • Anti-Inflammatory
  • Anti-Infective
  • Parasiticides

By Route of Administration:

  • Oral
  • Parental
  • Topical

By Services:

  • Diagnostic Tests and Imaging
  • Physical Health Monitoring
  • Surgery
  • Vaccination

By Distribution Channel:

  • Veterinary Hospital
  • Veterinary Clinics
  • Pharmacies and drug stores
  • E-commerce

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Equine Veterinary Therapeutics Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Drugs Lifecycle Analysis
  • 2.4. Equine Veterinary Therapeutics Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Equine Veterinary Therapeutics Market Outlook: Drugs
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Drugs, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
      • 3.3.3.1. Anti- Inflammatory
      • 3.3.3.2. Anti - Infective
      • 3.3.3.3. Parasiticides
      • 3.3.3.4. Others
  • 3.4. Market Attractiveness Analysis: Drugs
  • 3.5. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Route of Administration, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
      • 3.5.3.1. Oral
      • 3.5.3.2. Parental
      • 3.5.3.3. Topical
  • 3.6. Market Attractiveness Analysis: Route of Administration
  • 3.7. Global Equine Veterinary Therapeutics Market Outlook: Service
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Service, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
      • 3.7.3.1. Diagnostic Tests and Imaging
      • 3.7.3.2. Physical Health Monitoring
      • 3.7.3.3. Surgery
      • 3.7.3.4. Vaccination
      • 3.7.3.5. Others
  • 3.8. Market Attractiveness Analysis: Service
  • 3.9. Global Equine Veterinary Therapeutics Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
    • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
      • 3.9.3.1. Veterinary Hospital
      • 3.9.3.2. Veterinary Clinics
      • 3.9.3.3. Pharmacies and drug stores
      • 3.9.3.4. E-commerce
      • 3.9.3.5. Other
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Equine Veterinary Therapeutics Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Drugs
    • 5.3.3. By Route of Administration
    • 5.3.4. By Service
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 5.5.1. Anti- Inflammatory
    • 5.5.2. Anti - Infective
    • 5.5.3. Parasiticides
    • 5.5.4. Others
  • 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 5.6.1. Oral
    • 5.6.2. Parental
    • 5.6.3. Topical
  • 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 5.7.1. Diagnostic Tests and Imaging
    • 5.7.2. Physical Health Monitoring
    • 5.7.3. Surgery
    • 5.7.4. Vaccination
    • 5.7.5. Others
  • 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 5.8.1. Veterinary Hospital
    • 5.8.2. Veterinary Clinics
    • 5.8.3. Pharmacies and drug stores
    • 5.8.4. E-commerce
    • 5.8.5. Other
  • 5.9. Market Attractiveness Analysis

6. Europe Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Drugs
    • 6.3.3. By Route of Administration
    • 6.3.4. By Service
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 6.5.1. Anti- Inflammatory
    • 6.5.2. Anti - Infective
    • 6.5.3. Parasiticides
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 6.6.1. Oral
    • 6.6.2. Parental
    • 6.6.3. Topical
  • 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 6.7.1. Diagnostic Tests and Imaging
    • 6.7.2. Physical Health Monitoring
    • 6.7.3. Surgery
    • 6.7.4. Vaccination
    • 6.7.5. Others
  • 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 6.8.1. Veterinary Hospital
    • 6.8.2. Veterinary Clinics
    • 6.8.3. Pharmacies and drug stores
    • 6.8.4. E-commerce
    • 6.8.5. Other
  • 6.9. Market Attractiveness Analysis

7. East Asia Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Drugs
    • 7.3.3. By Route of Administration
    • 7.3.4. By Service
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 7.5.1. Anti- Inflammatory
    • 7.5.2. Anti - Infective
    • 7.5.3. Parasiticides
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 7.6.1. Oral
    • 7.6.2. Parental
    • 7.6.3. Topical
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 7.7.1. Diagnostic Tests and Imaging
    • 7.7.2. Physical Health Monitoring
    • 7.7.3. Surgery
    • 7.7.4. Vaccination
    • 7.7.5. Others
  • 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 7.8.1. Veterinary Hospital
    • 7.8.2. Veterinary Clinics
    • 7.8.3. Pharmacies and drug stores
    • 7.8.4. E-commerce
    • 7.8.5. Other
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Drugs
    • 8.3.3. By Route of Administration
    • 8.3.4. By Service
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 8.5.1. Anti- Inflammatory
    • 8.5.2. Anti - Infective
    • 8.5.3. Parasiticides
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 8.6.1. Oral
    • 8.6.2. Parental
    • 8.6.3. Topical
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 8.7.1. Diagnostic Tests and Imaging
    • 8.7.2. Physical Health Monitoring
    • 8.7.3. Surgery
    • 8.7.4. Vaccination
    • 8.7.5. Others
  • 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 8.8.1. Veterinary Hospital
    • 8.8.2. Veterinary Clinics
    • 8.8.3. Pharmacies and drug stores
    • 8.8.4. E-commerce
    • 8.8.5. Other
  • 8.9. Market Attractiveness Analysis

9. Latin America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Drugs
    • 9.3.3. By Route of Administration
    • 9.3.4. By Service
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 9.5.1. Anti- Inflammatory
    • 9.5.2. Anti - Infective
    • 9.5.3. Parasiticides
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 9.6.1. Oral
    • 9.6.2. Parental
    • 9.6.3. Topical
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 9.7.1. Diagnostic Tests and Imaging
    • 9.7.2. Physical Health Monitoring
    • 9.7.3. Surgery
    • 9.7.4. Vaccination
    • 9.7.5. Others
  • 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 9.8.1. Veterinary Hospital
    • 9.8.2. Veterinary Clinics
    • 9.8.3. Pharmacies and drug stores
    • 9.8.4. E-commerce
    • 9.8.5. Other
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Drugs
    • 10.3.3. By Route of Administration
    • 10.3.4. By Service
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 10.5.1. Anti- Inflammatory
    • 10.5.2. Anti - Infective
    • 10.5.3. Parasiticides
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 10.6.1. Oral
    • 10.6.2. Parental
    • 10.6.3. Topical
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 10.7.1. Diagnostic Tests and Imaging
    • 10.7.2. Physical Health Monitoring
    • 10.7.3. Surgery
    • 10.7.4. Vaccination
    • 10.7.5. Others
  • 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 10.8.1. Veterinary Hospital
    • 10.8.2. Veterinary Clinics
    • 10.8.3. Pharmacies and drug stores
    • 10.8.4. E-commerce
    • 10.8.5. Other
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Merck Animal Heath
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Affymetrix
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Elanco Animal Health
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Zoetis (Pfizer Animal Health)
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Equine Health UK
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations